Epigenetics in cancer development, diagnosis and therapy

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Cancer remains a leading global cause of mortality, with increasing incidence and death rates.
• Epigenetic mechanisms, particularly DNA methylation and histone modification, are increasingly recognized as critical in carcinogenesis.
• These epigenetic alterations are implicated in tumor formation and metastasis.

Purpose of the Study:

• To explore the role of epigenetics in cancer development.
• To highlight the diagnostic and therapeutic potential of targeting epigenetic modifications.
• To provide insight into the mechanism of carcinogenesis.

Main Methods:

• Review of existing scientific literature on epigenetics and cancer.
• Analysis of studies focusing on DNA methylation and histone modification in tumor formation.
• Examination of the development of diagnostic and therapeutic strategies based on epigenetic alterations.

Main Results:

• DNA methylation and histone modification are significant contributors to tumor formation and metastasis.
• Epigenetic understanding has led to the development of effective, accurate, and cost-effective cancer screening and diagnostic methods.
• Therapeutic approaches targeting epigenetic modifications show promise and have led to FDA-approved cancer drugs.

Conclusions:

• Epigenetic changes, including DNA methylation and histone modification, are integral to tumor growth.
• Epigenetics research holds significant promise for advancing cancer diagnostics and therapeutics.
• Targeting epigenetic alterations represents a viable strategy for combating cancer progression.